Ignite Creation Date:
2024-05-06 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05023655
Status:
RECRUITING
Last Update Posted:
2023-04-18
First Post:
2021-08-12
Brief Title:
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Sponsor:
Organization:
Prisma Health-Upstate